Skip to main content

Quest Diagnostics Inc(DGX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Quest and Proov Collaborate to Bring Novel Home Fertility Test to Women Through questhealth.com

PR Newswire - Thu Jul 6, 2023

First and only FDA-cleared PdG (progesterone metabolite) home test to help confirm successful ovulation

SECAUCUS, N.J., July 6, 2023 /PRNewswire/ -- Women seeking to start or expand a family can now access the Proov Confirm PdG home collection kit for assessing fertility through questhealth.com. Available through a collaboration with the consumer-initiated testing business of Quest Diagnostics (NYSE: DGX) and Proov, maker of at-home fertility and hormone tests, the Proov Confirm PdG test is the first and only FDA-cleared PdG (progesterone metabolite) home test kit to confirm successful ovulation.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.